1. Home
  2. STRRP vs REVBW Comparison

STRRP vs REVBW Comparison

Compare STRRP & REVBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRRP
  • REVBW
  • Stock Information
  • Founded
  • STRRP N/A
  • REVBW N/A
  • Country
  • STRRP United States
  • REVBW United States
  • Employees
  • STRRP 171
  • REVBW 9
  • Industry
  • STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • REVBW Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRRP Health Care
  • REVBW Health Care
  • Exchange
  • STRRP Nasdaq
  • REVBW Nasdaq
  • Market Cap
  • STRRP N/A
  • REVBW N/A
  • IPO Year
  • STRRP N/A
  • REVBW 2020
  • Fundamental
  • Price
  • STRRP $9.05
  • REVBW $0.02
  • Analyst Decision
  • STRRP
  • REVBW
  • Analyst Count
  • STRRP 0
  • REVBW 0
  • Target Price
  • STRRP N/A
  • REVBW N/A
  • AVG Volume (30 Days)
  • STRRP N/A
  • REVBW N/A
  • Earning Date
  • STRRP N/A
  • REVBW N/A
  • Dividend Yield
  • STRRP N/A
  • REVBW N/A
  • EPS Growth
  • STRRP N/A
  • REVBW N/A
  • EPS
  • STRRP N/A
  • REVBW N/A
  • Revenue
  • STRRP N/A
  • REVBW N/A
  • Revenue This Year
  • STRRP N/A
  • REVBW N/A
  • Revenue Next Year
  • STRRP N/A
  • REVBW N/A
  • P/E Ratio
  • STRRP N/A
  • REVBW N/A
  • Revenue Growth
  • STRRP N/A
  • REVBW N/A
  • 52 Week Low
  • STRRP N/A
  • REVBW N/A
  • 52 Week High
  • STRRP N/A
  • REVBW N/A
  • Technical
  • Relative Strength Index (RSI)
  • STRRP 48.17
  • REVBW N/A
  • Support Level
  • STRRP $8.82
  • REVBW N/A
  • Resistance Level
  • STRRP $9.28
  • REVBW N/A
  • Average True Range (ATR)
  • STRRP 0.19
  • REVBW 0.00
  • MACD
  • STRRP -0.01
  • REVBW 0.00
  • Stochastic Oscillator
  • STRRP 45.07
  • REVBW 0.00

About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

About REVBW Revelation Biosciences Inc. Warrant

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: